Skip to content
Aperlena
Free alerts

Germany - Pharmaceuticals - Discount agreements under Section 130a (8) SGB V as part of open-house procedures

Original Deutschland - Arzneimittel - Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren

Open Contract notice

Key facts

Closes in
709 days
Buyer
IKK classic
Where
Germany Dresden
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
German
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 5 days ago
Notice number
636646-2026
Watch this tender

If the deadline moves or the notice is corrected, we email you. Log in

  1. Published
  2. Today
  3. Deadline open for 721 days
  4. Awarded pending

Summary

Machine-generated summary

IKK classic, a German statutory health insurer, concludes non-exclusive rebate agreements with all interested and suitable pharmaceutical companies for various active substances and combinations under Section 130a (8) SGB V, on equal, non-negotiable terms within open-house procedures. The agreement period runs from 01.11.2026 to 31.10.2028. Accession is possible at any time during this period, at the latest until 05.09.2028. Products include albendazole, apixaban, aripiprazole depot formulations, colistimethate, dapagliflozin with and without metformin, dornase alfa, estriol, incobotulinumtoxin and onabotulinumtoxin, indacaterol and glycopyrronium, infliximab intravenous and subcutaneous, macrogol, multienzyme, nabilone, oseltamivir, piperacillin and tazobactam, pivmecillinam, prednicarbat and tobramycin inhalation capsules.

Description

Die IKK classic gibt hiermit bekannt, dass sie mit allen interessierten und geeigneten pharmazeutischen Unternehmen im Zeitraum vom 01.11.2026 bis zum 31.10.2028 zu verschiedenen Wirkstoffen und Wirkstoffkombinationen nicht-exklusive Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu gleichen, nicht verhandelbaren Bedingungen abschließen wird. Frühester Vertragsbeginn ist der 01.11.2026, sofern der unterschriebene Vertrag und alle nötigen Nachweise, Eigenerklärungen und Unterlagen bis zum 05.10.2026 bei der IKK classic eingehen. Danach gilt: Bei Eingang der Unterlagen bis zum 05. eines jeweiligen Monats im möglichen Beitrittszeitraum wird der jeweils 01. des Folgemonats Vertragsbeginn. Bei Eingang der Unterlagen nach dem 05. eines jeweiligen Monats im möglichen Beitrittszeitraum wird der jeweils 01. des übernächsten Folgemonats Vertragsbeginn. Ein Beitritt zur Vereinbarung ist im angegebenen Zeitraum jederzeit möglich, spätestens jedoch bis zum 05.09.2028. Weitere Angaben siehe Pkt. VI.3). Albendazol; ATC-Code: P02CA03; Apixaban; ATC-Code: B01AF02; Aripiprazol; Depotformulierungen; ATC-Code: N05AX12; Colistimethat; ATC-Code: J01XB01; Dapagliflozin; ATC-Code: A10BK01; Dapagliflozin und Metformin; ATC-Code: A10BD15; Dornase alfa; ATC-Code: R05CB13; Estriol; ATC-Code: G03CA04; Incobotulinumtoxin; ATC-Code: M03AX21 (ADV), M03AX01 (WHO); Indacaterol und Glycopyrronium; ATC-Code: R03AL04; Infliximab; intravenöse Applikation; ATC-Code: L04AB02; Infliximab; subkutane Applikation; ATC-Code: L04AB02; Macrogol; ATC-Code: A06AD15; Multienzyme; ohne 20.000 und 25.000 Einheiten; ATC-Code: A09AA02; Nabilon; ATC-Code: A04AD11; Onabotulinumtoxin; ATC-Code: M03AX21 (ADV), M03AX01 (WHO); Oseltamivir; ATC-Code: J05AH02; Piperacillin und Tazobactam; ATC-Code: J01CR05; Pivmecillinam; ATC-Code: J01CA08; Prednicarbat; ATC-Code: D07AC18; Tobramycin; Hartkapseln mit Pulver zur Inhalation; ATC-Code: J01GB01

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in German.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 5 days ago

View the official notice

More from this buyer

Full buyer profile

16 open tenders right now

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany

Company Wins Total awarded Last win
Siemens Healthineers AG 42 €17.4M Sep 2026
Philips GmbH 20 €5.3M Sep 2026
GlaxoSmithKline GmbH & Co. KG 15 n/a Sep 2026
ASTRAZENECA GMBH 12 n/a Jul 2026
Brainlab Sales GmbH 11 €4.9M Sep 2026

Based on 1019 awards with a linked company profile over the last 2 years.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,063,485
9,570 open across Europe right now
Buyer track record on Aperlena
70 notices tracked · 29 awarded
€462,107,931 in awarded contracts

Never miss a tender like this

58 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

709 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language